anti-inflammatory activity ivig mediated inhibitory fc receptor 
molecular basis anti-inflammatory property intravenous gamma globulin ivig investigated murine model immune thrombocytopenia administration clinically protective doses intact antibody monomeric fe fragments wild-type fc gamma receptor-humanized mice prevented platelet consumption triggered pathogenic autoantibody inhibitory pc receptor fc gamma riib required protection disruption either genetic deletion blocking monoclonal antibody reversed therapeutic effect ivig protection associated ability ivig administration induce surface expression fc gamma riib splenic macrophages modulation inhibitory signaling thus potent therapeutic strategy attenuating autoantibody-triggered inflammatory diseases 
